New combo therapy aims to ease pain and prevent opioid relapse
NCT ID NCT05571917
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 28 times
Summary
This study tests a treatment that combines two therapies—Acceptance and Commitment Therapy (ACT) and Mindfulness-Based Relapse Prevention (MBRP)—for people with both chronic pain and opioid use disorder. About 160 adults already stable on buprenorphine will either receive this integrated therapy or standard care. The goal is to see if the combined approach reduces pain interference and helps prevent relapse.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC PAIN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
-
University of New Mexico
Albuquerque, New Mexico, 87131, United States
Conditions
Explore the condition pages connected to this study.